Uncategorized Archives - Page 5 of 5 - KBA Attorneys

FDA Recall: Belviq, Belviq XR (lorcaserin) by Eisai: Drug Safety Communication – FDA Requests Withdrawal of Weight-Loss Drug

As of January 2020 the FDA issued the following safety communication: The FDA has requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the...

Mylan Pharmaceuticals Expands Recall For Valsartan Drugs

Early in December, Mylan Pharmaceuticals announced the expansion of its voluntary recall of valsartan products. The recall took place because it was found that the...

Johnson And Johnson Settles Risperdal Lawsuit

Johnson And Johnson, the makers of Risperdal, agreed to settle with a family from Mississippi. The family states their son developed breasts after taking Risperdal....

The Maker of Pradaxa, Boehringer Ingelheim, hit with $1.25 Million Verdict

A federal jury in Huntington, West Virginia, has awarded the family of a deceased West Virginia woman $1.25 Million. The jury found that Boehringer Ingelheim,...

Updates on the Zofran Litigation

We have previously written about a Zofran recall. A separate litigation already underway alleges the drug Zofran (Ondansetron) causes birth defects in babies born to...

Attorneys Representing Babies Born Addicted to Opioids Want To Join A Multi District Litigation

There is a multidistrict litigation that was formed in federal court in Ohio in December in which various cities, counties, and states, among others, have...

Purdue Pharma Knew its Opioids were Widely Abused

The responsible party for the opioid overdose crises, Purdue Pharma reportedly claimed that it was unaware of the misuse of its game changer product, OxyContin....